Royal Holloway University Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2014
NCT02310906
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Royal Holloway University | Simon M. Cutting